We recently reported the first case of germline loss of function mutations causing partial JAK1 deficiency in humans which resulted in immunodeficiency characterized by mycobacterial infection, suggesting a dominant effect on the IFNγ pathway, and high-grade bladder carcinoma (1). Here, JAK1 is linked to immunodeficiency disease.